Uncategorized

SGLT2 Inhibitors Modestly Increase Hemoglobin and Hematocrit

A meta-analysis of 85 randomized clinical trials involving 70,543 participants found that sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with small but statistically significant increases in hemoglobin and hematocrit levels compared with control treatments, although the clinical significance of these changes remains unclear. The trials had a median follow-up of 24 weeks. Hemoglobin increased by 0.55 g/dL in participants receiving SGLT2 inhibitors, compared with a decrease of 0.08 g/dL in the control group, resulting in a between-group difference of 0.60 g/dL. Hematocrit increased by 2.17 percentage points in the SGLT2 inhibitor group, compared with a change of −0.13 percentage points in the control group, yielding a between-group difference of 2.36 percentage points. Among the secondary outcomes, SGLT2 inhibitor use was also associated with increased erythropoietin levels and decreased transferrin saturation. These findings suggest that SGLT2 inhibitors influence red blood cell production and iron metabolism, but further research is needed to determine the clinical implications of these changes. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Modified Position Management Improved Outcomes in Heart Failure Patients

In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…

1 hour ago

Proteomic Study Identified Novel Ischemic Stroke Risk Factors

A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…

2 hours ago

T2D Linked to Higher Alzheimer’s Risk

People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…

2 hours ago

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

4 days ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

5 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

6 days ago

This website uses cookies.